2025;6:1001378 DOI: Received: October 01, 2025 Accepted: December 04, 2025 Published: December 17, 2025 Academic Editor: Alessandro Granito, University of Bologna, Italy The management of metabolic dysfunction-associated steatohepatitis (MASH) has evolved significantly, transitioning from a lack of therapeutic options to resmetiroma and semaglutide being licensed for use in MASH
Losartan Losartan is FDA-approved to: Treat high blood pressure (hypertension) in adults and children 6 years of age and older
In Phase 3 trials so far, its delivered up to 28.7% body-weight loss at 68 weeks at the 12 mg dose in adults with obesity and knee osteoarthritis, alongside meaningful reductions in knee pain
Use lactose-free cottage cheese if dairy tolerance is inconsistent
-
The reaction was worked up by extraction, washing with water (3) and brine